Dennis Leroy Stevens

Dennis Leroy Stevens's AcademicInfluence.com Rankings

Philosophy

#6648

World Rank

#9715

Historical Rank

Logic

#3780

World Rank

#4988

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Dennis Leroy Stevens's Degrees

Doctorate Medicine University of California, San Francisco
PhD Microbiology University of California, San Francisco

Why Is Dennis Leroy Stevens Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dennis Leroy Stevens's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Practice guidelines for the diagnosis and management of skin and soft-tissue infections. (2005) (2166)
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. (2014) (1240)
Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. (2014) (1034)
Streptococcal infections of skin and soft tissues. (1996) (982)
Recombinant Human Interleukin 1 Receptor Antagonist in the Treatment of Patients With Sepsis Syndrome: Results From a Randomized, Double-blind, Placebo-Controlled Trial (1994) (889)
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A (1989) (783)
Invasive group A streptococcus infections. (1992) (661)
Defining the group A streptococcal toxic shock syndrome. Rationale and consensus definition. The Working Group on Severe Streptococcal Infections. (1993) (638)
Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. (1990) (507)
Linezolid versus Vancomycin in Treatment of Complicated Skin and Soft Tissue Infections (2005) (452)
Impact of antibiotics on expression of virulence-associated exotoxin genes in methicillin-sensitive and methicillin-resistant Staphylococcus aureus. (2007) (441)
Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. (1995) (435)
The Eagle effect revisited: efficacy of clindamycin, erythromycin, and penicillin in the treatment of streptococcal myositis. (1988) (429)
Munumbicins, wide-spectrum antibiotics produced by Streptomyces NRRL 30562, endophytic on Kennedia nigriscans. (2002) (376)
Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. (1992) (359)
Severe sepsis and septic shock: review of the literature and emergency department management guidelines. (2006) (343)
Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. (2002) (311)
Virulence studies on chromosomal α‐toxin and Θ‐toxin mutants constructed by allelic exchange provide genetic evidence for the essential role of α‐toxin in Clostridium perfringens‐mediated gas gangrene (1995) (280)
Randomized Comparison of Linezolid (PNU-100766) versus Oxacillin-Dicloxacillin for Treatment of Complicated Skin and Soft Tissue Infections (2000) (244)
Necrotizing Soft-Tissue Infections. (2017) (230)
Identification and molecular analysis of a locus that regulates extracellular toxin production in Clostridium perfringens (1994) (202)
Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome (1991) (198)
Could nonsteroidal antiinflammatory drugs (NSAIDs) enhance the progression of bacterial infections to toxic shock syndrome? (1995) (194)
Penicillin-binding protein expression at different growth stages determines penicillin efficacy in vitro and in vivo: an explanation for the inoculum effect. (1993) (189)
Streptococcal toxic shock syndrome: synthesis of tumor necrosis factor and interleukin-1 by monocytes stimulated with pyrogenic exotoxin A and streptolysin O. (1992) (187)
Spontaneous, nontraumatic gangrene due to Clostridium septicum. (1990) (186)
Clostridium sordellii infection: epidemiology, clinical findings, and current perspectives on diagnosis and treatment. (2006) (186)
Streptococcal toxic shock syndrome associated with necrotizing fasciitis. (2000) (181)
The role of vancomycin in the treatment paradigm. (2006) (174)
Life-threatening clostridial infections. (2009) (159)
The flesh-eating bacterium: what's next? (1999) (155)
Effect of antibiotics on toxin production and viability of Clostridium perfringens (1987) (151)
Antibiotic effects on bacterial viability, toxin production, and host response. (1995) (143)
Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. (2002) (136)
A review of linezolid: the first oxazolidinone antibiotic (2004) (133)
Group A streptococcal bacteremia: the role of tumor necrosis factor in shock and organ failure. (1996) (129)
The role of clostridial toxins in the pathogenesis of gas gangrene. (2002) (128)
Comparison of clindamycin, rifampin, tetracycline, metronidazole, and penicillin for efficacy in prevention of experimental gas gangrene due to Clostridium perfringens. (1987) (126)
Genetic and phenotypic diversity among isolates of Streptococcus pyogenes from invasive infections. (1996) (119)
Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. (2000) (118)
Invasive group A streptococcal infections: the past, present and future (1994) (117)
Superantigens associated with staphylococcal and streptococcal toxic shock syndrome are potent inducers of tumor necrosis factor-beta synthesis. (1993) (113)
Clostridial Gas Gangrene: Evidence That α and θ Toxins Differentially Modulate the Immune Response and Induce Acute Tissue Necrosis (1997) (107)
Selective Depletion Of Vβ-Bearing T Cells In Patients With Severe Invasive Group A Streptococcal Infections And Streptococcal Toxic Shock Syndrome (1995) (107)
Investigation of the role of the disulphide bond in the activity and structure of staphylococcal enterotoxin C1 (1994) (107)
Group A streptococcal myonecrosis: increased vimentin expression after skeletal-muscle injury mediates the binding of Streptococcus pyogenes. (2006) (104)
Lethal effects and cardiovascular effects of purified alpha- and theta-toxins from Clostridium perfringens. (1988) (103)
Clostridial gas gangrene. II. Phospholipase C-induced activation of platelet gpIIbIIIa mediates vascular occlusion and myonecrosis in Clostridium perfringens gas gangrene. (2000) (95)
Phospholipase C and perfringolysin O from Clostridium perfringens upregulate endothelial cell-leukocyte adherence molecule 1 and intercellular leukocyte adherence molecule 1 expression and induce interleukin-8 synthesis in cultured human umbilical vein endothelial cells (1996) (95)
The toxic shock syndromes. (1996) (94)
Vascular dysfunction and ischemic destruction of tissue in Streptococcus pyogenes infection: the role of streptolysin O-induced platelet/neutrophil complexes. (2005) (92)
Clostridial gas gangrene. I. Cellular and molecular mechanisms of microvascular dysfunction induced by exotoxins of Clostridium perfringens. (2000) (89)
In vitro production of panton-valentine leukocidin among strains of methicillin-resistant Staphylococcus aureus causing diverse infections. (2007) (81)
Pregnancy-related group a streptococcal infections: temporal relationships between bacterial acquisition, infection onset, clinical findings, and outcome. (2013) (80)
Evaluation of an Intervention Designed to Decrease the Rate of Nosocomial Methicillin-Resistant Staphylococcus aureus Infection by Encouraging Decreased Fluoroquinolone Use (2006) (79)
Spread of serious disease-producing M3 clones of group A streptococcus among family members and health care workers. (1996) (79)
Immunization with the C-Domain of alpha -Toxin prevents lethal infection, localizes tissue injury, and promotes host response to challenge with Clostridium perfringens. (2004) (79)
Effects of α and θ Toxins from Clostridium perfringens on Human Polymorphonuclear Leukocytes (1987) (78)
Clostridium perfringens invasiveness is enhanced by effects of theta toxin upon PMNL structure and function: the roles of leukocytotoxicity and expression of CD11/CD18 adherence glycoprotein. (1993) (75)
Successful treatment of staphylococcal toxic shock syndrome with linezolid: a case report and in vitro evaluation of the production of toxic shock syndrome toxin type 1 in the presence of antibiotics. (2006) (73)
Molecular epidemiology of nga and NAD glycohydrolase/ADP-ribosyltransferase activity among Streptococcus pyogenes causing streptococcal toxic shock syndrome. (2000) (71)
The pathogenesis of clostridial myonecrosis. (2000) (66)
Comparison of single and combination antimicrobial agents for prevention of experimental gas gangrene caused by Clostridium perfringens (1987) (65)
Haemophilus influenzae pneumonia in adults. (1977) (64)
Clostridial Myonecrosis: New Insights in Pathogenesis and Management (2010) (63)
Health care-associated infection (HAI): a critical appraisal of the emerging threat-proceedings of the HAI Summit. (2008) (63)
Familial transmission of a serious disease--producing group A streptococcus clone: case reports and review. (1997) (62)
Pathogenesis of Clostridium perfringens infection: mechanisms and mediators of shock. (1997) (62)
Evaluation of therapy with hyperbaric oxygen for experimental infection with Clostridium perfringens. (1993) (59)
Antibiotic susceptibilities of human isolates of Pasteurella multocida (1979) (56)
Clostridial gas gangrene: evidence that alpha and theta toxins differentially modulate the immune response and induce acute tissue necrosis. (1997) (56)
Clostridium perfringens phospholipase C-induced platelet/leukocyte interactions impede neutrophil diapedesis. (2006) (55)
Invasive group A streptococcal infection: New concepts in antibiotic treatment. (1994) (55)
Staging of the baboon response to group A streptococci administered intramuscularly: a descriptive study of the clinical symptoms and clinical chemical response patterns. (1999) (53)
Analysis of circulating phagocyte activity measured by whole blood luminescence: correlations with clinical status. (1994) (49)
Persistent acylation of high-molecular-weight penicillin-binding proteins by penicillin induces the postantibiotic effect in Streptococcus pyogenes. (1994) (48)
Muscle injury, vimentin expression, and nonsteroidal anti-inflammatory drugs predispose to cryptic group A streptococcal necrotizing infection. (2008) (48)
Impetigo, Erysipelas and Cellulitis (2016) (47)
Identification and Characterization of Bicistronic speB and prsA Gene Expression in the Group A Streptococcus (2006) (47)
Augmented production of Panton-Valentine leukocidin toxin in methicillin-resistant and methicillin-susceptible Staphylococcus aureus is associated with worse outcome in a murine skin infection model. (2010) (45)
Effects of Clostridium perfringens recombinant and crude phospholipase C and theta-toxin on rabbit hemodynamic parameters. (1995) (45)
Tigecycline suppresses toxin A and B production and sporulation in Clostridium difficile. (2015) (44)
Construction and virulence testing of a collagenase mutant of Clostridium perfringens. (2000) (44)
Spontaneous C. septicum gas gangrene: A literature review. (2017) (43)
The circulating phagocyte reflects the in vivo state of immune defense (1992) (43)
Phenotypes and genotypes of erythromycin-resistant Streptococcus pyogenes strains isolated from invasive and non-invasive infections from Mexico and the USA during 1999-2010. (2012) (42)
Epidemiologic investigation of methicillin resistant Staphylococcus aureus in a burn unit. (1978) (42)
In Vitro Antimicrobial Effects of Various Combinations of Penicillin and Clindamycin against Four Strains of Streptococcus pyogenes (1998) (41)
Effects of selective and nonselective nonsteroidal anti-inflammatory drugs on antibiotic efficacy of experimental group A streptococcal myonecrosis. (2014) (40)
Community-acquired Staphylococcus aureus infections: Increasing virulence and emerging methicillin resistance in the new millennium. (2003) (40)
Dilemmas in the treatment of invasive Streptococcus pyogenes infections. (2003) (39)
Activation of platelet gpIIbIIIa by phospholipase C from Clostridium perfringens involves store-operated calcium entry. (2003) (38)
Invasive group A streptococcal disease. (1996) (37)
Group A streptococcal sepsis (2003) (37)
Effects of ciprofloxacin on the expression and production of exotoxins by Clostridium difficile. (2013) (36)
The Pathogenesis of Gas Gangrene (1997) (36)
Clinical courses of seven survivors of Clostridium septicum infection and their immunologic responses to alpha toxin. (1994) (34)
An outbreak of group A Streptococcal infection among health care workers. (2002) (33)
Treatments for skin and soft-tissue and surgical site infections due to MDR Gram-positive bacteria. (2009) (33)
Structural Biology of Bacterial Pathogenesis (2006) (33)
Serious group a streptococcal infections. (2013) (32)
Effects of alpha and theta toxins from Clostridium perfringens on human polymorphonuclear leukocytes. (1987) (32)
The roles of injury and nonsteroidal anti-inflammatory drugs in the development and outcomes of severe group A streptococcal soft tissue infections (2015) (31)
Editorial Response: Rationale for the Use of Intravenous Gamma Globulin in the Treatment of Streptococcal Toxic Shock Syndrome (1998) (31)
The leukemoid reaction in Clostridium sordellii infection: neuraminidase induction of promyelocytic cell proliferation. (2007) (30)
Immune modulatory effects of antibiotics (1996) (29)
Comparison of adherence to and penetration of a human laryngeal epithelial cell line by group A streptococci of various M protein types. (1999) (29)
Necrotizing Clostridial Soft Tissue Infections (1997) (29)
Staphylococcus aureus α-hemolysin promotes platelet-neutrophil aggregate formation. (2013) (29)
Streptococcal toxic shock syndrome. (2002) (29)
The toxins of group A streptococcus, the flesh eating bacteria. (1997) (28)
M Type 1 and 3 Group A Streptococci Stimulate Tissue Factor-Mediated Procoagulant Activity in Human Monocytes and Endothelial Cells (2003) (26)
Fatal S. aureus Hemorrhagic Pneumonia: Genetic Analysis of a Unique Clinical Isolate Producing both PVL and TSST-1 (2011) (26)
β‐Adrenoceptor‐mediated modulation of calcium ionophore activated polymorphonuclear leucocytes (1986) (23)
The first case of Pasteurella canis bacteremia: a cirrhotic patient with an open leg wound (2010) (22)
Origin of Cyanide in Cultures of a Psychrophilic Basidiomycete (1968) (22)
Variable susceptibility to opsonophagocytosis of group A streptococcus M-1 strains by human immune sera. (1999) (22)
Role of θ Toxin, a Sulfhydryl-Activated Cytolysin, in the Pathogenesis of Clostridial Gas Gangrene (1993) (22)
Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections. (2009) (22)
Novel therapies in streptococcal toxic shock syndrome: attenuation of virulence factor expression and modulation of the host response. (1998) (22)
Necrotizing Soft Tissue Infections. (2020) (21)
Sequential computerized axial tomography in tuberculous meningitis. (1978) (21)
Mycobacterium fortuitum Meningitis Associated with an Epidural Catheter: Case Report and a Review of the Literature (1999) (20)
vfr, a Novel Locus Affecting Cysteine Protease Production in Streptococcus pyogenes (2009) (19)
Cardiac Myocyte Dysfunction Induced by Streptolysin O Is Membrane Pore and Calcium Dependent (2015) (19)
Streptococcal pyrogenic exotoxin A and streptolysin O enhance polymorphonuclear leukocyte binding to gelatin matrixes. (1992) (18)
Invasive streptococcal infections (2001) (18)
Direct effects of purified staphylococcal toxic shock syndrome toxin 1 on myocardial function of isolated rabbit atria. (1989) (18)
Role of theta toxin, a sulfhydryl-activated cytolysin, in the pathogenesis of clostridial gas gangrene. (1993) (17)
Opsonization of T1M1 group A Streptococcus: dynamics of antibody production and strain specificity. (2001) (17)
Invasive Group A Streptococcal Infections (2002) (16)
Selective depletion of V beta-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. Ontario Streptococcal Study Project. (1995) (16)
Comparison of oral cefpodoxime proxetil and cefaclor in the treatment of skin and soft tissue infections. (1993) (16)
Rationale for the use of intravenous gamma globulin in the treatment of streptococcal toxic shock syndrome. (1998) (16)
Comparative efficacy of antibiotics in treating experimental Clostridium septicum infection. (2018) (16)
Superantigens: their role in infectious diseases. (1997) (16)
Streptococcus pyogenes: Basic Biology to Clinical Manifestations [Internet] (2016) (15)
Teicoplanin for skin and soft tissue infections: An open study and a randomized, comparative trial versus cefazolin (1999) (15)
Current Approaches to Group A Streptococcal Vaccine Development -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations (2016) (14)
Severe Group A Streptococcal Infections (2016) (14)
Innate immune recognition of, and response to, Clostridium sordellii. (2010) (13)
Cytokines: an updated compendium (1995) (13)
Gram-positive shock (1992) (12)
The in vitro antibacterial activity of ceftriaxone against Streptococcus pyogenes is unrelated to penicillin-binding protein 4. (1993) (12)
Group B streptococcal osteomyelitis in adults. (1978) (11)
Netter's Infectious Disease (2014) (11)
Effects of delayed NSAID administration after experimental eccentric contraction injury – A cellular and proteomics study (2017) (11)
Clostridium perfringens enterotoxin lacks superantigenic activity but induces an interleukin-6 response from human peripheral blood mononuclear cells (1997) (10)
Emerging erythromycin and clindamycin resistance in group A streptococcus: Efficacy of linezolid and tedizolid in experimental necrotizing infection. (2020) (10)
Efficacy of Iclaprim in Complicated Skin and Skin Structure Infections: Preliminary Results of ASSIST-1 (2007) (10)
Haemophilus influenzae pneumonia in adults. (1972) (10)
Advances in the medical management of skin and soft tissue infections (2016) (9)
Effects of environmental factors on streptococcal erythrogenic toxin A (SPE A) production by Streptococcus pyogenes. (1997) (9)
The effects of iclaprim on exotoxin production in methicillin‐resistant and vancomycin‐intermediate Staphylococcus aureus (2019) (9)
Necrotizing Soft-Tissue Infections. (2018) (8)
Synergistic interaction of cefotaxime and its metabolite desacetylcefotaxime demonstrated by drug-impregnated disks. (1989) (8)
Streptococcal Toxic Shock Syndrome (STSS) (1997) (8)
Subinhibitory concentrations of tedizolid potently inhibit extracellular toxin production by methicillin‐sensitive and methicillin‐resistant Staphylococcus aureus (2019) (8)
Antimicrobial agents for complicated skin and skin-structure infections: noninferiority margins, placebo-controlled trials, and the complexity of clinical trials. (2009) (7)
Editorial Response: Varicella Gangrenosa with Toxic Shock—Like Syndrome (1995) (7)
A novel murine model of Clostridium sordellii myonecrosis: Insights into the pathogenesis of disease. (2016) (7)
Fidaxomicin reduces early toxin A and B production and sporulation in Clostridium difficile in vitro (2017) (7)
Group A streptococcus--from basic science to clinical disease. (1996) (6)
Virulence-Related Transcriptional Regulators of Streptococcus pyogenes -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations (2016) (5)
Reply to González del Castillo et al and Rashid and Kravitz. (2015) (5)
Editorial Response: Severe Invasive Streptococcal Infections (1993) (5)
Amebic liver abscess. Report of a case presenting with nonreactive serologic tests for Entamoeba histolytica. (1979) (5)
Clostridium perfringens and Other Life-Threatening Clostridial Soft Tissue Infections (2015) (4)
Chapter 10 – Necrotizing fasciitis, gas gangrene, myositis and myonecrosis (2010) (4)
199 – Streptococcus pyogenes (2015) (4)
Genetics of MRSA: The United States and Worldwide (2007) (4)
‘Flesh-eating’ necrotizing infections: must we amputate? (2012) (4)
Enrichment of Antigen-Specific Class-Switched B Cells from Individuals Naturally Immunized by Infection with Group A Streptococcus (2019) (4)
Cardiac dysfunction in StrepTSS: group A streptococcus disrupts the directional cardiomyocyte-to-macrophage crosstalk that maintains macrophage quiescence. (2012) (4)
Pathogenesis and the immune response (1997) (4)
Do cardiomyocytes mount an immune response to Group A Streptococcus? (2011) (4)
Streptolysin O modulates cytokine synthesis in human peripheral blood mononuclear cells. (1997) (3)
Subinhibitory Dalbavancin Attenuates Exotoxin Production from Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureusIn Vitro (2017) (3)
Differential white blood cell count: underutilized or overrated. (2000) (3)
Efficacy of Tedizolid in Experimental Myonecrosis caused by Erythromycin/Clindamycin-Sensitive and -Resistant Group A Streptococcus (2016) (3)
Toll receptors, CD14, MD-2 and NOD2: their role in health and acute and chronic infectious diseases. (2002) (3)
Type-specific opsonophagocytosis of group A Streptococcus by use of a rapid chemiluminescence assay. (1999) (3)
CHAPTER 55 – Clostridial toxins in the pathogenesis of gas gangrene (2006) (2)
Streptococcal and staphylococcal infections. (2019) (2)
A NEW PRIMATE MODEL OF GROUP A STREPTOCOCCAL NECROTIZING FACIITIS/MYOSITIS.: 153 (1996) (2)
Effects of Iclaprim and Trimethoprim on Exotoxin Production by Methicillin-resistant Staphylococcus aureus (2017) (2)
Botulism, gas gangrene, and clostridial gastrointestinal infections (2010) (2)
Chapter 9 – Cellulitis, pyoderma, abscesses and other skin and subcutaneous infections (2010) (2)
Streptococcal toxic shock syndrome (STSS). An update: a roundtable presentation. (1997) (2)
Group B streptococcal infection in 1987. (1987) (2)
Streptococcal Infections (2009) (2)
The origin of cyanide in a psychrophilic basidiomycete (1967) (2)
Folliculitis, Furuncles, and Carbuncles (2012) (1)
Erysipelas and Cellulitis (2012) (1)
CURRENT CONCEPTS IN THE TREATMENT OF STREPTOCOCCAL PHARYNGITIS (1998) (1)
Expression of activational markers on circulating leukocytes from baboons with group A streptococcal (GAS) bacteremia. (1997) (1)
Current Opinion in Infectious Diseases (2009) (1)
The Comparative Efficacy of Antibiotics against Experimental Clostridium septicum Infection (2016) (1)
Skin and soft tissue infections: Cellulitis, fasciitis, and myonecrosis (2004) (1)
In the clinic. Cellulitis and soft-tissue infections. (2009) (1)
Editorial (2019) (1)
11 – Necrotizing Fasciitis, Gas Gangrene, Myositis and Myonecrosis (2017) (1)
10 – Cellulitis, Pyoderma, Abscesses, and Other Skin and Subcutaneous Infections (2017) (1)
Infections due to Gram-Positive Cocci (2009) (1)
New Aspects of Group A streptococcal Infection (1997) (1)
Subinhibitory Concentrations of Tedizolid Effectively Inhibit Extracellular Toxin Production by Methicillin-Sensitive and Methicillin-Resistant Staphylococcus aureus (2016) (1)
Immunomodulation for the treatment and prevention of bacterial infections: a challenge for the next millennium. (1999) (1)
Pathogenesis and immune response cellular interactions of virulence factor (1994) (1)
Predicting and Defining Vancomycin Efficacy: Program Overview (2006) (1)
Sub‐lethal doses of surotomycin and vancomycin have similar effects on Clostridium difficile virulence factor production in vitro (2018) (1)
Bacterial shock: clinical definitions, clinical trials and the dynamics of the host response. (2001) (1)
NECROTIZING INFECTIONS CAUSED BY GRAM-POSITIVE BACTERIA : A PERSONAL PERSPECTIVE (1998) (0)
New Insights into Necrotising Fasciitis (2009) (0)
Streptococcus groups A, B, C, D, and G (2021) (0)
Editorial: Pathogenesis and host response in the era of modern diagnostics: let's continue the basics. (2019) (0)
Figure 1. [Anatomical relationship between skin and...]. (2016) (0)
Immunity and host response. (1998) (0)
Recent Advances in Pharmacology and Toxicology Applying Computational Systems Biology Techniques to Nutraceutical Research (2015) (0)
Editorial: Pathogenesis and immune response - editorial. (2022) (0)
35 – Introduction to Systemic Infections (2011) (0)
Virulence Mechanisms of Bacterial Pathogens (2009) (0)
Infections Due to Streptococcus pneumoniae (2019) (0)
The role of cytokines and growth factors in the production activation of the circulating phagocyte (1995) (0)
Predicting and Defining Vancomycin Efficacy: Posttest and Program Evaluation (2006) (0)
OL-024 vfr: A novel locus affecting cysteine protease production in Streptococcus pyogenes (2009) (0)
Combating “The Flesh-Eating Disease,” Increasing Our Understanding of How Two Toxins Destroy Our Cells (2020) (0)
Influence of Combination Therapy on Toxin Production (2008) (0)
Contributors (2015) (0)
Skin, soft tissue, bone, and joint infections (1995) (0)
Virulence Factors of Streptococcuspyogenes (2004) (0)
Atlas of infectious diseases. Volume 2: skin, soft tissue, bone, and joint infections. (1995) (0)
Netter's infectious diseases (2011) (0)
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity (2023) (0)
Infections of the skin and soft tissue (2012) (0)
Clinical Infectious Disease: Streptococcus groups A, B, C, D, and G (2015) (0)
Reply to Eljaaly et al. (2015) (0)
Streptococci and enterococci (2010) (0)
UvA-DARE ( Digital Academic Repository ) Staging of the baboon response to group A streptococci administered intramuscul ; ary : a descriptive study of the clinical symptoms and clinical chemical response patterns (1999) (0)
Investigating the immunomodulatory activities of omadacycline (2022) (0)
Group a Streptococcal and Staphylococcal Infections (2011) (0)
Comprar Netter's Infectious Diseases (Print + Web Version) | Elaine C. Jong | 9780323374750 | Saunders (2016) (0)
Introduction to Skin and Soft-Tissue Infections (2012) (0)
Identiﬁcation and Characterization of Bicistronic speB and prsA Gene Expression in the Group A Streptococcus (cid:1) (2006) (0)
A critical role of tumor necrosis factor (TNF) alpha in experimental group A streptococcal (GAS) bacteremia. (1997) (0)
Exotoxins From Methicillin-resistant Staphylococcus Aureus (MRSA) Uniquely Induce Alveolar Epithelial/pulmonary Endothelial Cell Cross-talk (2010) (0)
Emerging Treatments for Resistant Bacterial Infections and Pathogen-Focused Therapy (2008) (0)
Comprar Netter's Infectious Diseases Book and Online Access at www.NetterReference.com Print + Web Version | Elaine C. Jong | 9781437701258 | Saunders (2011) (0)
Infections Due to Staphylococci (2019) (0)
Exotoxins from Community-Acquired MRSA, Other Than Panton-Valentine Leukocidin, Induce Neutrophil Activation and Platelet Binding. (2009) (0)
The basic science of clinical observations (1996) (0)
Streptococcus pyogenes NAD+-Glycohydrolase Reduces Skeletal Muscle βNAD+ Levels Independently of Streptolysin O (2022) (0)
Comprar Netter's Infectious Diseases Print Version Only | Elaine C. Jong | 9781437701265 | Saunders (2011) (0)
Pathogenesis and immune response:Editorial overview (1992) (0)
Life-Threatening Skin and Soft-Tissue Infections (2012) (0)
Pathogenesis and immune response: editorial Biomedical research discoveries: acceptance, controversies and current challenges to improving human health. (2023) (0)
Characterization of Paeniclostridium sordellii Metalloproteinase-1 in vitro and in an experimental model of infection. (2021) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dennis Leroy Stevens?

Dennis Leroy Stevens is affiliated with the following schools: